Heart · 2015 · 28 citations · 19 references
MedicineCardiologyInternal MedicineClinical CardiologyClinical EpidemiologyRheumatologyCardiovascular DiseaseCardiovascular EpidemiologyHeart FailurePacific HealthAcute Rheumatic FeverAnnual IncidenceCardiac Outcome AssessmentCardiovascular Disease IncidenceCardiovascular Disease PrevalenceHeart Failure EpidemiologySevere Cardiac DiseaseStroke Embolism
OBJECTIVES: Rheumatic heart disease (RHD) remains the leading acquired heart disease in the young worldwide. We aimed at assessing outcomes and influencing factors in the contemporary era. METHODS: Hospital-based cohort in a high-income island nation where RHD remains endemic and the population is captive. All patients admitted with newly diagnosed RHD according to World Heart Federation echocardiographic criteria were enrolled (2005-2013). The incidence of major cardiovascular events (MACEs) including heart failure, peripheral embolism, stroke, heart valve intervention and cardiovascular death was calculated, and their determinants identified. RESULTS: Of the 396 patients, 43.9% were male with median age 18 years (IQR 10-40)). 127 (32.1%) patients presented with mild, 131 (33.1%) with moderate and 138 (34.8%) with severe heart valve disease. 205 (51.8%) had features of acute rheumatic fever. 106 (26.8%) presented with at least one MACE. Among the remaining 290 patients, after a median follow-up period of 4.08 (95% CI 1.84 to 6.84) years, 7 patients (2.4%) died and 62 (21.4%) had a first MACE. The annual incidence of first MACE and of heart failure were 59.05‰ (95% CI 44.35 to 73.75) and 29.06‰ (95% CI 19.29 to 38.82), respectively. The severity of RHD at diagnosis (moderate vs mild HR 3.39 (0.95 to 12.12); severe vs mild RHD HR 10.81 (3.11 to 37.62), p<0.001) and ongoing secondary prophylaxis at follow-up (HR 0.27 (0.12 to 0.63), p=0.01) were the two most influential factors associated with MACE. CONCLUSIONS: Newly diagnosed RHD is associated with poor outcomes, mainly in patients with moderate or severe valve disease and no secondary prophylaxis.
19
Rafael Lozano, Mohsen Naghavi, Kyle J Foreman et al. · The Lancet · 2012 · 14.3K citations · Full text
Prevalence of Rheumatic Heart Disease Detected by Echocardiographic Screening
Éloi Marijon, Phalla Ou, David S. Celermajer et al. · New England Journal of Medicine · 2007 · 804 citations · Full text
Medicine, Cardiology, Pediatrics +12
Rheumatic Fever and Rheumatic Heart Disease
Edward F. Bland, DUCKETT JONES · Circulation · 1951 · 618 citations · Full text